Results 111 to 120 of about 3,013 (168)

Modulation of Cardiometabolic Risk by Vitamin D and K2: Simple Supplementation or Real Drug? Uncovering the Pharmacological Properties. [PDF]

Int J Mol Sci
D'Elia S, Bottino R, Carbone A, Formisano T, Orlandi M, Sperlongano S, Castaldo P, Molinari D, Palladino A, Morello M, Titolo G, Loffredo FS, Natale F, Cirillo P, Cimmino G.   +14 more
europepmc   +1 more source

Two journeys, one diagnosis: exploring the clinical outcomes of twins with congenital myopathy. [PDF]

BMC Neurol
Pera MC, Pisanò G, Gnazzo M, Moretti S, Gambini L, Percesepe A, Esposito S, Perrone S.   +7 more
europepmc   +1 more source

Adjunctive Active Vitamin D Decreases Kidney Function during Treatment of Secondary Hyperparathyroidism with Extended-Release Calcifediol in Non-Dialysis Chronic Kidney Disease in a Randomized Trial.

Am J Nephrol
Ashfaq A, Choe J, Strugnell SA, Patel N, Sprague SM, Norris KC, Lerma E, Petkovich PM, Bishop CW, Ashfaq A.   +9 more
europepmc   +1 more source

Calcifediol Treatment and COVID-19–Related Outcomes [PDF]

Journal of Clinical Endocrinology and Metabolism, 2021
Abstract Context COVID-19 is a major health problem because of saturation of intensive care units (ICU) and mortality. Vitamin D has emerged as a potential treatment able to reduce the disease severity.
Natalia Garcia-Giralt, Xavier Noguès, Roger Bouillon   +2 more
exaly   +7 more sources

Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency [PDF]

Nutrients, 2020
Vitamin D deficiency is a global health problem due to its high prevalence and its negative consequences on musculoskeletal and extra-skeletal health. In our comparative review of the two exogenous vitamin D supplementation options most used in our care setting, we found that cholecalciferol has more scientific evidence with positive results than ...
Manuel Sosa-Henriquez
exaly   +6 more sources

Some of the next articles are maybe not open access.

Related searches:

Effects of Calcifediol on Calcified Tissue in Uremia

Archives of Internal Medicine, 1978
Disorders in the synthesis of the active metabolites of vitamin D, 1,2 dialysate calcium (Ca) concentration, 3 dietary Ca and phosphorus (P), 4 and secondary hyperparathyroidism 5 have been shown to influence Ca metabolism and the severity of the bone disease associated with uremia.
L M, Kleinman, J M, Letteri, S N, Asad, K J, Ellis, S H, Cohn   +4 more
openaire   +3 more sources